Symbiotec Pharmalab shares to begin trading on BSE from Sept 1, 2026

Capital Market EventsExplain this filing

SYMBIOTEC · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction

Awaiting price reaction for this filing.

AI summary

Symbiotec Pharmalab Ltd has been listed on BSE under scrip code 544889. Its equity shares will be admitted to trading on the exchange effective from September 1, 2026. The announcement marks the company's formal entry into the public market, enabling investors to buy and sell the stock from that date.

Likely market impact

Marks the company's public market debut on BSE. Investors can begin buying and selling the stock from Sept 1, 2026.